Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

A role of androgen receptor protein in cell growth of an androgen-independent prostate cancer cell line.

Furutani T, Takeyama K, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, Kato S.

Biosci Biotechnol Biochem. 2005 Nov;69(11):2236-9.

2.

Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.

Furutani T, Takeyama K, Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, Kato S.

J Pharmacol Exp Ther. 2005 Nov;315(2):545-52. Epub 2005 Aug 3. Retraction in: J Pharmacol Exp Ther. 2014 Mar;348(3):493.

3.

Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.

Miyauchi T, Fujimori A, Maeda S, Iemitsu M, Sakai S, Shikama H, Tanabe T, Matsuda M, Goto K, Yamaguchi I.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S64-7.

PMID:
15838361
4.

YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.

Fujimori A, Miyauchi T, Sakai S, Yuyama H, Iemitsu M, Sanagi M, Sudoh K, Goto K, Shikama H, Yamaguchi I.

J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S354-7.

PMID:
15838319
5.

Macrophage-derived lipoprotein lipase increases aortic atherosclerosis in cholesterol-fed Tg rabbits.

Ichikawa T, Liang J, Kitajima S, Koike T, Wang X, Sun H, Morimoto M, Shikama H, Watanabe T, Yamada N, Fan J.

Atherosclerosis. 2005 Mar;179(1):87-95. Epub 2004 Dec 25.

PMID:
15721013
6.

Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits.

Wang X, Liang J, Koike T, Sun H, Ichikawa T, Kitajima S, Morimoto M, Shikama H, Watanabe T, Sasaguri Y, Fan J.

Am J Pathol. 2004 Oct;165(4):1375-83.

7.

Macrophage-specific overexpression of human matrix metalloproteinase-12 in transgenic rabbits.

Fan J, Wang X, Wu L, Matsumoto SI, Liang J, Koike T, Ichikawa T, Sun H, Shikama H, Sasaguri Y, Watanabe T.

Transgenic Res. 2004 Jun;13(3):261-9.

PMID:
15359603
8.

Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis.

Ichikawa T, Kitajima S, Liang J, Koike T, Wang X, Sun H, Okazaki M, Morimoto M, Shikama H, Watanabe T, Yamada N, Fan J.

Lab Invest. 2004 Jun;84(6):715-26.

9.

Antithrombotic and thrombolytic efficacy of YM-254890, a G q/11 inhibitor, in a rat model of arterial thrombosis.

Kawasaki T, Taniguchi M, Moritani Y, Hayashi K, Saito T, Takasaki J, Nagai K, Inagaki O, Shikama H.

Thromb Haemost. 2003 Sep;90(3):406-13.

PMID:
12958608
10.

YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.

Ugawa T, Kakuta H, Moritani H, Inagaki O, Shikama H.

Br J Pharmacol. 2003 May;139(1):140-6.

11.

Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats.

Kurosaki E, Nakano R, Momose K, Shimaya A, Suzuki T, Shibasaki M, Shikama H.

Eur J Pharmacol. 2003 May 9;468(2):151-8.

PMID:
12742522
12.

Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation.

Kurosaki E, Nakano R, Shimaya A, Yoshida S, Ida M, Suzuki T, Shibasaki M, Shikama H.

Biochem Pharmacol. 2003 Mar 1;65(5):795-805.

PMID:
12628477
13.

Effects of mild and moderate hypothermia on apoptosis in neuronal PC12 cells.

Shibano T, Morimoto Y, Kemmotsu O, Shikama H, Hisano K, Hua Y.

Br J Anaesth. 2002 Aug;89(2):301-5.

14.

Hypoglycemic agent YM440 ameliorates the impaired hepatic glycogenesis after glucose loading by increasing glycogen synthase activity in obese Zucker rats.

Kurosaki E, Momose K, Nakano R, Shimaya A, Suzuki T, Shibasaki M, Shikama H.

Jpn J Pharmacol. 2002 Jul;89(3):274-81.

15.

Inhibitory effects of the new anti-inflammatory agent, IS-741, on spontaneous colitis in HLA-B27/beta2-microglobulin transgenic rats.

Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Imamura M, Fujiyama Y, Bamba T.

J Gastroenterol Hepatol. 2002 Aug;17(8):854-60.

PMID:
12164961
16.

A novel MPL point mutation resulting in thrombopoietin-independent activation.

Abe M, Suzuki K, Inagaki O, Sassa S, Shikama H.

Leukemia. 2002 Aug;16(8):1500-6.

17.

Stabilization of androgen receptor protein is induced by agonist, not by antagonists.

Furutani T, Watanabe T, Tanimoto K, Hashimoto T, Koutoku H, Kudoh M, Shimizu Y, Kato S, Shikama H.

Biochem Biophys Res Commun. 2002 Jun 21;294(4):779-84.

PMID:
12061774
18.

Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.

Ugawa T, Kakuta H, Moritani H, Shikama H.

Br J Pharmacol. 2002 Mar;135(6):1572-8.

19.

Suppressive effects of a new anti-inflammatory agent, IS-741, on dextran sulfate sodium-induced experimental colitis in rats.

Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Araki Y, Fujiyama Y, Bamba T.

Int J Mol Med. 2002 Apr;9(4):391-6.

PMID:
11891534
20.

Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.

Ichikawa T, Unoki H, Sun H, Shimoyamada H, Marcovina S, Shikama H, Watanabe T, Fan J.

Am J Pathol. 2002 Jan;160(1):227-36.

Supplemental Content

Loading ...
Support Center